Clinical Trials Browser

Phase 2 × Solid Tumor × dalpiciclib × Clear all

NCT05512780 2022-08-23

Dalpiciclib Combined With Letrozole in Neoadjuvant Treatment of Stage Ⅱ-Ⅲ HR-positive/HER2-negative Breast Cancer

Phase 2 Unknown

Other solid neoplasm

Solid Tumor